We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Probe May Detect Early Cancer

By Biotechdaily staff writers
Posted on 24 Aug 2005
Scientists have discovered a new way to spot subtle chemical changes in the growth of tumors, which may aid the early detection of cancer and other diseases. More...
Their findings were reported in the August 14, 2005, issue of Nature Chemical Biology.

A molecule that can label proteases--protein-chewing enzymes that blast into overdrive in cancerous cells--has been created by Matthew Bogyo, Ph.D., assistant professor of pathology, and colleagues at Stanford University School of Medicine (Palo Alto, CA, USA). The new molecule contains a fluorescent tag that flashes brightly enough to be seen with conventional imaging equipment.

This new activity-based probe is unusual in that it only lights up when the proteases are active. Since it works in living cells, the probe could potentially be used for whole-body imaging for the detection of early warning signs of cancer. Proteases work overtime in tumors that are getting ready to spread, or metastasize, and in angiogenesis. Other cells with hyperactive proteases include cells affected by arthritis, osteoporosis, atherosclerosis, and neurodegenerative disorders such as Alzheimer's.

"This is an important tool for understanding the biochemistry of proteases, and how they play a role in diseases like cancer,” said Dr. Bogyo. "And it's noninvasive and fairly nontoxic, in that it doesn't involve radioisotopes.”

The probe has a number of advantages over other enzyme imaging probes. In one innovation, the scientists added a chemical subunit called a quencher that keeps the probe dark until the protease is activated. The chemical changes activating the enzyme switch the probe on "like a molecular beacon,” noted Dr. Boygo. Since the probe is small enough to pass easily across cell membranes, it can be used inside living cells. The probe also forms a permanent bond with its targeted protease, allowing it to track where the protease is active.

In addition to making new probes, Dr. Bogyo and his team are working on imaging applications. "We have made the tool, now we want to go and use it,” observed Galia Blum, a postdoctoral scholar in Dr. Bogyo's lab and the study's lead author. "Our next step is to generate whole-body images in mice.”





Related Links:
Stanford Medical School

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Cancer cells (red) stick to mesothelial cells (green) and form hybrid spheres that cut into surrounding abdominal tissue (Photo courtesy of Uno et al., 2026)

Abdominal Fluid Testing Can Predict Ovarian Cancer Progression

Ovarian cancer kills more women than any other gynecological cancer, largely because it is usually diagnosed only after it has spread widely within the abdomen. Unlike many other cancers, it does not rely... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.